FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Eywa Pharma Levetiracetam Tablets Recall

Levetiracetam Tablets, USP 500 mg, packaged in 120-count bottle, Rx only, Manufactured…

EYWA PHARMA INC · Princeton, NJ

Risk level
Class II
Reported by FDA
Dec 2, 2020
Recall ID
D-0109-2021
Check your lot numberHow we source this data

Summary

Eywa Pharma recalled Levetiracetam Tablets starting Nov 10, 2020. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0109-2021 on Dec 2, 2020. Reason: Presence of foreign tablet/capsule: A 1000 mg Levetiracetam Tablet was found in 500 gram bottle of Levetiracetam Tablets. Status: Terminated.

Why it was recalled

Presence of foreign tablet/capsule: A 1000 mg Levetiracetam Tablet was found in 500 gram bottle of Levetiracetam Tablets.

Product description

Levetiracetam Tablets, USP 500 mg, packaged in 120-count bottle, Rx only, Manufactured by: VKT Pharma Private Limited Srikakulam, India - 532 409, Manufactured for: Eywa Pharma Inc. 2 Research Way, Floor 3 Princeton, NJ 08540, NDC 71930-063-52

Lot numbers, UPCs & expiration codes

Lot #: LEV5019021A, Exp 10/2021

Where it was sold

USA Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0109-2021
Classification
Class II
Status
Terminated
Recall initiated
Nov 10, 2020
FDA report date
Dec 2, 2020
Quantity
5451 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
EYWA PHARMA INC

Original FDA data

Every field from FDA enforcement report D-0109-2021, exactly as published.

Show all FDA fields
City
Princeton
State
NJ
Status
Terminated
Country
United States
Event ID
86740
Address
2 Research Way
Address (line 2)
Floor 3
Code information
Lot #: LEV5019021A, Exp 10/2021
Postal code
08540-6628
Report date
Dec 2, 2020
Product type
Drugs
Recall number
D-0109-2021
Classification
Class II
Recalling firm
EYWA PHARMA INC
Product quantity
5451 bottles
Termination date
Oct 16, 2024
Reason for recall
Presence of foreign tablet/capsule: A 1000 mg Levetiracetam Tablet was found in 500 gram bottle of Levetiracetam Tablets.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Levetiracetam Tablets, USP 500 mg, packaged in 120-count bottle, Rx only, Manufactured by: VKT Pharma Private Limited Srikakulam, India - 532 409, Manufactured for: Eywa Pharma Inc. 2 Research Way, Floor 3 Princeton, NJ 08540, NDC 71930-063-52
Distribution pattern
USA Nationwide
Recall initiation date
Nov 10, 2020
Initial firm notification
Letter
Center classification date
Nov 25, 2020

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0109-2021, published Dec 2, 2020. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls